Browsing Category

Top Industry News

7674 posts

Roche’s Genentech Breaks Ground on $750-M Device Fill–Finish US Facility Expansion 
By

By
Roche’s Genentech has broken ground on a $750-million, 211,000-square-foot expansion of its manufacturing facility in Hillsboro, Oregon, to add device fill–finish capabilities, including the manufacturing of combination products. The investment…

AstraZeneca Takes $2-Bn Equity Stake in Summit Therapeutics 
By

By
AstraZeneca has agreed to take a $2-billion equity stake in Summit Therapeutics, a Miami-based bio/pharmaceutical company, and the companies have formed a clinical collaboration to evaluate Summit’s lead drug candidate,…

Sanofi Expands Antibody Pact with Regeneron in $8-Bn Deal 
By

By
Sanofi has expanded its antibody collaboration with Regeneron Pharmaceuticals, a Tarrytown, New York-based bio/pharmaceutical company, to add four new drug candidates in an $8-billion deal ($1 billion upfront and $7…

Novo, Hengrui Pharma in $2.6-Bn Deal for Oral GLP-1R/GIPR Obesity Drug 
By

By
Novo has entered into a license agreement with Hengrui Pharma, a Shanghai-based bio/pharmaceutical company, for HRS-1596, a Phase I-ready glucagon-like peptide-1 receptor (GLP-1R) and gastric inhibitory polypeptide receptor (GIPR) dual…

Supplier News: SK pharmteco, Esteve CDMO, Vetter & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring SK pharmteco, Esteve CDMO, Vetter, Sharp Services, Piramal Pharma Solutions, SPI Pharma, Colorcon, Lonza, and Bespak.   Chemicals/Chemical API Manufacturing * SK pharmteco To…

Global Briefs: Merck & Co., Roche, Lilly & More 
By

By
A roundup of news from the large and mid-sized bio/pharmaceutical companies featuring Merck & Co., Roche, Eli Lilly and Company, AbbVie, Tanabe Pharma, and PhRMA. Highlights below.   For the latest…

Biotech Briefs: ADARx, Varda & More 
By

By
The latest from small and Emerging Pharma companies featuring ADARx, Varda Space and Scynexis.  For news on the large and mid-sized bio/pharmaceutical companies, see Global Briefs.  * ADARx Files $446…

Lilly Breaks Ground on $6.5-Bn Houston API Manufacturing Facility 
By

By
Eli Lilly and Company has broken ground on its previously announced $6.5-billion small-molecule medicines and advanced therapeutics manufacturing facility in Houston, Texas. The facility is part of the company’s $50-billion…

European Executives Call on National Govt’s To Prioritize Pharma Industry 
By

By
The Chairs of eight European and globally headquartered bio/pharmaceutical companies (AstraZeneca, Boehringer Ingelheim, Chiesi Group, Ipsen, GSK, Novo, Novartis, Roche, and Sanofi) issued an Open Letter calling on European policymakers…

European Pharma Industry Comments on Proposed Framework for AI Infrastructure 
By

By
The European Federation of Pharmaceutical Industries and Associations (EFPIA), which represents bio/pharmaceutical innovator companies and national pharmaceutical trade associations, issued a statement to “welcome” the European Commission’s proposal for a…